Research Article

MitoQ Modulates Lipopolysaccharide-Induced Intestinal Barrier Dysfunction via Regulating Nrf2 Signaling

Figure 5

MitoQ decreases intestinal and systemic inflammatory agents in sepsis. Inflammatory cytokines in plasma (a) and intestines (b) were measured by ELISA kits. Plasma and intestinal NO levels were evaluated by Griess Reagent kit. Data are expressed as the . vs. control group; # vs. LPS group.
(a)
(b)
(c)
(d)